Tseganesh Asefa Yifru1, Sezer Kisa2, Negalign Getahun Dinegde3, Niguse Tadele Atnafu4. 1. School of Nursing, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia. 2. Department of Nursing and Health Promotion, Faculty of Health Sciences, Oslo Metropolitan University, Oslo, Norway. 3. Department of Nursing, School of Nursing & Midwifery, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia. 4. Department of Nursing, School of Nursing & Midwifery, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia. niguse.tadele@aau.edu.et.
Abstract
OBJECTIVE: Impaired swallowing is a primary medical concern in head and neck cancer (HNC) patients. Swallowing therapy and supportive care to relieve swallowing problems among HNC patients are recommended. However, no data shows the effect of dysphagia on the quality of life (QoL) among Ethiopian patients. This cross-sectional study aimed to assess swallowing function and its impact on QoL. RESULTS: The sample included 102 HNC patients who visited oncology clinics at Tikur Anbessa Specialized Hospital. Majority were male (53.90%), employed (70.6%), single (57.80%), and completed some level of formal education (66.60%) with a mean age of 42.58 years (SD ± 14.08). More than half of the patients (69.6%) medical expenses were covered by the government. Most were suffering from advanced stage HNC (59.80%), squamous cell carcinoma (62.70%), and the most prevalent tumor location was nasopharynx (40.20%). The mean MDADI score was 53.29 (SD ± 15.85). Being female, low income, suffering from laryngeal cancer, advanced tumor, and undergoing a single modality therapy were crucial determinants of poor QoL related to swallowing problems. It is recommended to assess swallowing related QoL of patients using a validated tool and be included in treatment protocols.
OBJECTIVE: Impaired swallowing is a primary medical concern in head and neck cancer (HNC) patients. Swallowing therapy and supportive care to relieve swallowing problems among HNC patients are recommended. However, no data shows the effect of dysphagia on the quality of life (QoL) among Ethiopian patients. This cross-sectional study aimed to assess swallowing function and its impact on QoL. RESULTS: The sample included 102 HNC patients who visited oncology clinics at Tikur Anbessa Specialized Hospital. Majority were male (53.90%), employed (70.6%), single (57.80%), and completed some level of formal education (66.60%) with a mean age of 42.58 years (SD ± 14.08). More than half of the patients (69.6%) medical expenses were covered by the government. Most were suffering from advanced stage HNC (59.80%), squamous cell carcinoma (62.70%), and the most prevalent tumor location was nasopharynx (40.20%). The mean MDADI score was 53.29 (SD ± 15.85). Being female, low income, suffering from laryngeal cancer, advanced tumor, and undergoing a single modality therapy were crucial determinants of poor QoL related to swallowing problems. It is recommended to assess swallowing related QoL of patients using a validated tool and be included in treatment protocols.
Entities:
Keywords:
Dysphagia; Head and neck cancer; Impaired swallowing; MDADI; Quality of life
Authors: Julie A Ames; Lucy Hynds Karnell; Anjali K Gupta; Todd C Coleman; Michael P Karnell; Douglas J Van Daele; Gerry F Funk Journal: Head Neck Date: 2010-11-12 Impact factor: 3.147
Authors: Carrie D Llewellyn; Debbie J Horney; Mark McGurk; John Weinman; Jim Herold; Keith Altman; Helen E Smith Journal: Psychooncology Date: 2011-09-14 Impact factor: 3.894
Authors: Bryce B Reeve; Jianwen Cai; Hongtao Zhang; Mark C Weissler; Kathy Wisniewski; Heather Gross; Andrew F Olshan Journal: Laryngoscope Date: 2016-05-25 Impact factor: 3.325
Authors: Katherine A Hutcheson; Martha P Barrow; Asher Lisec; Denise A Barringer; Kacie Gries; Jan S Lewin Journal: Laryngoscope Date: 2015-11-06 Impact factor: 3.325
Authors: Maria Giulia Cristofaro; Ida Barca; Francesco Ferragina; Daniela Novembre; Yvelise Ferro; Roberta Pujia; Tiziana Montalcini Journal: J Transl Med Date: 2021-11-22 Impact factor: 5.531